Details for New Drug Application (NDA): 214806
✉ Email this page to a colleague
The generic ingredient in THEOPHYLLINE is theophylline. There are thirty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the theophylline profile page.
Summary for 214806
Tradename: | THEOPHYLLINE |
Applicant: | Harman Finochem |
Ingredient: | theophylline |
Patents: | 0 |
Suppliers and Packaging for NDA: 214806
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
THEOPHYLLINE | theophylline | TABLET, EXTENDED RELEASE;ORAL | 214806 | ANDA | Sun Pharmaceutical Industries Limited | 70095-017 | 70095-017-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70095-017-01) |
THEOPHYLLINE | theophylline | TABLET, EXTENDED RELEASE;ORAL | 214806 | ANDA | Sun Pharmaceutical Industries Limited | 70095-018 | 70095-018-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70095-018-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 300MG | ||||
Approval Date: | Oct 24, 2023 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 450MG | ||||
Approval Date: | Oct 24, 2023 | TE: | AB | RLD: | No |
Complete Access Available with Subscription